Outputs for Dana-Farber Cancer Institute (DFCI)

1 August 2019 - 31 July 2020

United States of America (USA)

Country: United States Of America (USA)

Sector: Healthcare

Subject/journal group: All

Count Share
420 54.79

The research outputs below are grouped by journal. Click on the journal to view the list of articles.

Journal Count Share
ACS Nano 6 0.41
Advanced Functional Materials 9 0.22
Advanced Materials 5 0.11
American Journal of Human Genetics 2 0.69
Analytical Chemistry 2 0.27
Angewandte Chemie International Edition 6 0.99
Cancer Cell 13 3.22
Cancer Research 16 3.90
Cell 15 2.43
Cell Host & Microbe 1 0
Cell Metabolism 4 0.23
Cell Stem Cell 13 2.02
Chemical Communications 2 0.02
Chemical Science 1 0.03
Current Biology 1 0.01
Developmental Cell 5 0.19
Genes & Development 5 0.52
Genome Research 2 0.04
Immunity 3 0.17
Journal of Biological Chemistry 6 2.20
Journal of Cell Biology 2 0.76
Journal of Clinical Investigation 12 1.24
Journal of Experimental Medicine 3 0.81
Journal of Neuroscience 1 0.01
Journal of the American Chemical Society 3 0.55
Molecular Cell 10 1.78
Nature 34 3.35
Nature Biotechnology 8 0.88
Nature Cell Biology 8 1.39
Nature Chemical Biology 7 1.33
Nature Chemistry 1 0.05
Nature Communications 80 10.37
Nature Genetics 19 2.54
Nature Immunology 4 0.68
Nature Materials 1 0.12
Nature Medicine 16 2.43
A single-cell landscape of high-grade serous ovarian cancer
2020-06-22
0.37
Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes
2020-06-22
0.63
Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis
2020-06-01
0.25
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma
2020-05-29
0.38
Geospatial immune variability illuminates differential evolution of lung adenocarcinoma
2020-05-27
0
BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
2020-05-25
0.02
A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors
2020-05-11
0.18
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
2020-04-23
0
Integrated single-cell analysis of multicellular immune dynamics during hyperacute HIV-1 infection
2020-03-23
0
Therapeutic base editing of human hematopoietic stem cells
2020-03-16
0.04
The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research
2020-02-10
0.21
Antitumor activity of crizotinib in lung cancers harboring a exon 14 alteration
2020-01-13
0.10
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
2019-12-02
0.12
Adipsin preserves beta cells in diabetic mice and associates with protection from type 2 diabetes in humans
2019-11-07
0.02
Genome-wide germline correlates of the epigenetic landscape of prostate cancer
2019-10-07
0.10
Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers
2019-09-09
0.01
Nature Methods 5 0.20
Nature Nanotechnology 1 0.03
Nature Neuroscience 2 0.02
Nature Structural & Molecular Biology 2 0.86
PLOS Biology 1 0
PLOS Genetics 2 0.08
Physical Review Letters 1 0.01
Proceedings of the National Academy of Sciences of the United States of America 26 3.29
Proceedings of the Royal Society B 1 0.01
Science 13 1.49
Science Advances 26 1.90
Science Translational Medicine 8 0.25
The ISME Journal: Multidisciplinary Journal of Microbial Ecology 1 0.02
eLife 5 0.67

Return to institution outputs